Diazepam and Demyelination - a phase IV clinical study of FDA data

Summary:

Demyelination is reported as a side effect among people who take Diazepam (diazepam), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Prednisolone, and have Crohn's disease.

The phase IV clinical study analyzes which people have Demyelination when taking Diazepam. It is created by eHealthMe based on reports of 105,904 people who have side effects when taking Diazepam from the FDA, and is updated regularly.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.

What is Demyelination?

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function) is found to be associated with 461 drugs and 669 conditions by eHealthMe. Check the latest studies of Demyelination.

On Aug, 02, 2026

105,904 people reported to have side effects when taking Diazepam.
Among them, 42 people (0.04%) have Demyelination.

Among these 42 people:

How long have people been on Diazepam when they have Demyelination? *

What is the gender of people who have Demyelination when taking Diazepam? *

female: 54.76 %
male: 45.24 %

What is the age of people who have Demyelination when taking Diazepam? *

What are other drugs people take besides Diazepam? *

What are other side effects people have besides Demyelination? *

Weakness: 15 people, 35.71%
Abdominal Pain: 14 people, 33.33%
Drug Ineffective: 12 people, 28.57%
Depression: 12 people, 28.57%
Insomnia (sleeplessness): 12 people, 28.57%
Joint Pain: 11 people, 26.19%
Speech Impairment (Adult) (inability to speak (adult)): 9 people, 21.43%
Neuropathy Peripheral (surface nerve damage): 8 people, 19.05%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 19.05%
Memory Loss: 8 people, 19.05%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 19.05%
Fistula (an abnormal connection or passageway between two): 7 people, 16.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 16.67%
Weakness: 6 people, 14.29%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 11.90%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 11.90%
Depression: 4 people, 9.52%
High Blood Cholesterol: 4 people, 9.52%
Pain: 4 people, 9.52%
Essential Hypertension (primary hypertension): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Diazepam and have Demyelination?

- Check whether Demyelination is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diazepam:

Diazepam (108,384 reports)

Demyelination treatments and more:

Demyelination (5,739 reports)

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Demyelination:

Demyelination (461 drugs)

Browse all the conditions that are associated with Demyelination:

Demyelination (669 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Diazepam) and Diazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.